by Global Regulatory Writing and Consulting | Apr 12, 2021 | Chemistry, Manufacturing, and Controls, Generics
By Rebecca Lynch April 13th, 2021 This year Global is excited to target a new growth area in generic drug submissions (ANDAs, or Abbreviated New Drug Applications). We’ve built a strong foundation in CMC and small molecule submissions, and we think our expertise in...
Recent Comments